À propos de cet article


Ince PG, Codd GA. Return of the cycad hypothesis - does the amyotrophic lateral sclerosis/parkinsonism dementia complex (ALS/PDC) of Guam have new implications for global health? Neuropath Appl Neurobiol 2005;31:345-53.10.1111/j.1365-2990.2005.00686.xSearch in Google Scholar

Sonnen JA, Larson EB, Gray SL, Wilson A, Kohama SG, Crane PK, Breitner JC, Montine TJ. Free radical damage to cerebral cortex in Alzheimer's disease, microvascular brain injury, and smoking. Ann Neurol 2009;65:226-9.10.1002/ana.21508Search in Google Scholar

Hirsch-Reinshagen V, Burgess BL, Wellington CL. Why lipids are important for Alzheimer disease? Mol Cell Biochem 2009;326:121-9.10.1007/s11010-008-0012-2Search in Google Scholar

Letenneur L, Pérès K, Fleury H, Garrigue I, Barberger-Gateau P, Helmer C, Orgogozo JM, Gauthier S, Dartigues JF. Seropositivity to herpes simplex virus antibodies and risk of Alzheimer's disease: a population-based cohort study. PLoS One 2008;3:e3637.10.1371/journal.pone.0003637Search in Google Scholar

Brar S, Henderson D, Schenck J, Zimmerman EA. Iron accumulation in the substantia nigra of patients with Alzheimer disease and parkinsonism. Arch Neurol 2009;66:371-4.10.1001/archneurol.2008.586Search in Google Scholar

Luquin MR, Obeso JA, Herrero MT, Laguna J, Martínez-Lage J. Parkinsonismo inducido por MPTP como modelo experimental de enfermedad de Parkinson: Similitudes y difernencias [Parkinsonism induced by MPTP as an experimental model of Parkinson disease: Similarities and differences, in Spanish]. Neurologia 1991;6:287-94.Search in Google Scholar

Fuentes JA, Longo VG. An investigation on the central effects of harmine, harmaline and related beta-carbolines. Neuropharmacolog 1971;10:15-23.10.1016/0028-3908(71)90004-9Search in Google Scholar

Barragan LA, Delhaye-Bouchaud N, Laget P. Druginduced activation of the inferior olivary nucleus in young rabbits. Differential effects of harmaline and quipazine. Neuropharmacology 1985;24:645-54.10.1016/0028-3908(85)90107-8Search in Google Scholar

Schinkel AH, Smit JJ, van Tellingen O, Beijnen JH, Wagenaar E, van Deemter L, Mol CAAM, van der Valk MA, Robanus-Maandag EC, te Riele HPJ, Berns AJM, Borst P. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 1994;77:491-502.10.1016/0092-8674(94)90212-7Search in Google Scholar

Rubin LL, Staddon JM. The cell biology of the blood-brain barrier. Annu Rev Neurosci 1999;22:11-28.10.1146/annurev.neuro.22.1.11Search in Google Scholar

Bradbury MWB, editor. The Concept of a Blood-Brain Barrier. 1st ed. Chichester: John Wiley; 1979.10.1016/0166-2236(79)90016-XSearch in Google Scholar

Gelderblom WC, Jaskiewicz K, Marasas WF, Thiel PG, Horak RM, Vleggaar R, Kriek NP. Fumonisins - novel mycotoxins with cancer-promoting activity produced by Fusarium moniliforme. Appl Environ Microbiol 1988;54:1806-11.10.1128/aem.54.7.1806-1811.1988Search in Google Scholar

Miller JD. Factors that affect the occurrence of fumonisin. Environ Health Perspect 2001;109(Suppl 2):321-4.10.1289/ehp.01109s2321Search in Google Scholar

Merrill AH Jr, Sullards MC, Wang E, Voss KA, Riley RT. Sphingolipid metabolism: roles in signal transduction and disruption by fumonisins. Environ Health Perspect 2001;109(Suppl 2):283-9.10.1289/ehp.01109s2283Search in Google Scholar

Merrill AH Jr, Liotta DC, Riley RT. Fumonisins: fungal toxins that shed light on sphingolipid function. Trends Cell Biol 1996;6:218-23.10.1016/0962-8924(96)10021-0Search in Google Scholar

Kellerman TS, Marasas WF, Thiel PG, Gelderblom WC, Cawood M, Coetzer JA. Leukoencephalomalacia in two horses induced by oral dosing of fumonisin B1. Onderstepoort J Vet Res 1990;57:269-75.Search in Google Scholar

Colvin BM, Harrison LR. Fumonisin-induced pulmonary edema and hydrothorax in swine. Mycopathologia 1992;117:79-82.10.1007/BF00497282Search in Google Scholar

Dutton MF. Fumonisins, mycotoxins of increasing importance: their nature and their effects. Pharmacol Ther 1996;70:137-61.10.1016/0163-7258(96)00006-XSearch in Google Scholar

Shephard GS, Thiel PG, Sydenham EW, Alberts JF, Gelderblom WC. Fate of a single dose of the 14C-labelled mycotoxin, fumonisin B1, in rats. Toxicon 1992;30:768-70.10.1016/0041-0101(92)90011-SSearch in Google Scholar

Voss KA, Bacon CW, Norred WP, Chapin RE, Chamberlain WJ, Plattner RD, Meredith FI. Studies on the reproductive effects of Fusarium moniliforme culture material in rats and the biodistribution of [14C] fumonisin B1 in pregnant rats. Nat Toxins 1996;4:24-33.10.1002/19960401NT4Search in Google Scholar

Brown DW, McCoy CP, Rottinghaus GE. Experimental feeding of Fusarium moniliforme culture material containing fumonisin B1 to channel catfish, Ictalurus punctatus. J Vet Diagn Invest 1994;6:123-4.10.1177/104063879400600128Search in Google Scholar

Rapoport SI, Matthews K, Thompson HK, Pettigrew KD. Osmotic opening of the blood-brain barrier in the rhesus monkey without measurable brain edema. Brain Res 1977;136:23-9.10.1016/0006-8993(77)90128-7Search in Google Scholar

Lillie RD, editor. Histopathologic Technic and Practical Histochemistry. 3rd ed. New York (NY): McGraw-Hill Book Co.; 1965.Search in Google Scholar

Scheinker IM. Cerebral swelling: Histopathology, classification and clinical significance of brain edema. J Neurosurg 1947;4:255-75.10.3171/jns.1947.4.3.0255Search in Google Scholar

Long DM, Hartmann JF, French LA. The ultrastructure of human cerebral edema. J Neuropathol Exp Neurol 1966;25:373-95.10.1097/00005072-196607000-00003Search in Google Scholar

Riley RT, Wang E, Schroeder JJ, Smith ER, Plattner RD, Abbas H, Yoo HS, Merrill AH Jr. Evidence for disruption of sphingolipid metabolism as a contributing factor in the toxicity and carcinogenicity of fumonisins. Nat Toxins 1996;4:3-15.10.1002/19960401NT2Search in Google Scholar

Marasas WFO, Kellerman TS, Gelderblom WCA, Coetzer JAW, Thiel PG, van der Lugt JJ. Leukoencephalomalacia in a horse induced by fumonsin B1 isolated from Fusarium moniliforme. Onderstepoort J Vet Res 1988;55:197-203.Search in Google Scholar

Harrison LR, Colvin BM, Greene JT, Newman LE, Cole Jr, JR. Pulmonary edema and hydrothorax in swine produced by fumonisin B1, a toxic metabolite of Fusarium moniliforme. J Vet Diagn Invest 1990;2:217-21.10.1177/104063879000200312Search in Google Scholar

Tsunoda M, Dugyala RR, Sharma RP. Fumonisin B1-induced increases in neurotransmitter metabolite levels in different brain regions of BALB/c mice. Comp Biochem Psysiol C Pharmacol Toxicol Endocrinol 1998;120(3):457-46510.1016/S0742-8413(98)10061-0Search in Google Scholar

Kwon OS, Sandberg JA, Slikker W, Jr. Effects of fumonisin B1 treatment on blood-brain barrier transfer in developing rats. Neurotoxicol Teratol 1997;19(2):151-15510.1016/S0892-0362(96)00217-6Search in Google Scholar

Lumlertdacha S, Lovell RT, Shelby RA, Lenz SD, Kemppainen BW. Growth, hematology and histopathology of channel catfish, Ictalurus punctatus, fed toxins from F. moniliforme. Aquaculture 1995;130:201-18.10.1016/0044-8486(94)00219-ESearch in Google Scholar

Marshall WJ, Bangert SK, editors. Clinical Biochemistry: Metabolic and Clinical Aspects. 2nd ed. Edinburgh: Elsevier Health Sciences; 2008.Search in Google Scholar

Sharma RP, Bhandari N, Tsunoda M, Riley RT, Voss KA, Meredith FI. Fumonisin toxicity in a transgenic mouse model lacking the mdr1a/1b P-glycoprotein genes. Environ Toxicol Pharmacol 2000;8:173-82.10.1016/S1382-6689(00)00038-7Search in Google Scholar

Osuchowski MF, He Q, Sharma RP. Endotoxin exposure alters brain and liver effects of fumonisin B1 in BALB/c mice: implication of blood brain barrier. Food Chem Toxicol 2005;43:1389-97.10.1016/j.fct.2005.03.01415913876Search in Google Scholar

Zanic-Grubisic T, Santini A, Cepelak I, Barisic K, Juretic D, Pepeljnjak S. Influence of ochratoxin A treatment on the activity of membrane bound enzymes in rat brain regions. Biol Chem Hoppe Seyler 1996;377:121-7.10.1515/bchm3.1996.377.2.1218868067Search in Google Scholar

Belmadani A, Tramu G, Betbeder AM, Steyn PS, Creppy EE. Regional selectivity to ochratoxin A, distribution and cytotoxicity in rat brain. Arch Toxicol 1998;72:656-62.10.1007/s0020400505579851682Search in Google Scholar

Wu SN, Chen H, Liu YC, Chiang HT. Block of L-type Ca2+ current by beauvericin, a toxic cyclopeptide, in the NG108-15 neuronal cell line. Chem Res Toxicol 2002;15:854-60.10.1021/tx020003k12067253Search in Google Scholar

Jestoi M. Emerging fusarium-mycotoxins fusaproliferin, beauvericin, enniatins, and moniliformin: a review. Crit Rev Food Sci Nutr 2008;48:21-49.10.1080/1040839060106202118274964Search in Google Scholar

Osuchowski MF, Edwards GL, Sharma RP. Fumonisin B1-induced neurodegeneration in mice after intracerebroventricular infusion is concurrent with disruption of sphingolipid metabolism and activation of proinflammatory signaling. Neurotoxicology 2005;26:212-21.10.1016/j.neuro.2004.10.00115713342Search in Google Scholar

Kwon OS, Schmued LC, Slikker W Jr. Fumonisin B1 in developing rats alters brain sphinganine levels and myelination. Neurotoxicology 1997;18:571-9.Search in Google Scholar

Sunyer J. The neurological effects of air pollution in children. Eur Respir J 2008;32:535-7.10.1183/09031936.0007370818757691Search in Google Scholar

Anglais, Slovenian
4 fois par an
Sujets de la revue:
Medicine, Basic Medical Science, other